Stock Events

Penumbra 

€176.55
31
+€3.15+1.82% Friday 19:55

Statistics

Day High
177.9
Day Low
175.05
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
6.66B
P/E Ratio
550.16
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0.11
0.33
0.54
0.76
Expected EPS
0.714133
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0P8.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap120.45B
Boston Scientific offers a wide range of medical devices that compete with Penumbra's neurovascular and peripheral vascular products.
Medtronic
MDT
Mkt Cap113.61B
Medtronic provides medical devices for various conditions, including those that overlap with Penumbra's market, such as neurovascular devices.
Smith & Nephew
SNN
Mkt Cap13.45B
Smith & Nephew competes in the medical technology market, offering products that can be used in similar procedures as Penumbra's.
Stryker
SYK
Mkt Cap137.35B
Stryker operates in the medical technology field, offering neurotechnology and spine products that compete with Penumbra's offerings.
Zimmer Biomet
ZBH
Mkt Cap23.51B
Zimmer Biomet competes in the musculoskeletal healthcare market, which can overlap with Penumbra's interventional therapies.
Edwards Lifesciences
EW
Mkt Cap42.14B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the broader cardiovascular market with Penumbra.
Intuitive Surgical
ISRG
Mkt Cap175.06B
Intuitive Surgical, known for its robotic surgical systems, competes in the high-tech end of medical devices, indirectly competing with Penumbra's innovative solutions.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its medical devices segment, offers a broad range of products that compete across several of Penumbra's markets.
Integra Lifesciences
IART
Mkt Cap1.58B
Integra LifeSciences offers products in neurosurgery, reconstructive and general surgery, directly competing with some of Penumbra's surgical solutions.

About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Show more...
CEO
Mr. Adam Elsesser
Employees
4200
Country
US
ISIN
US70975L1070
WKN
000A14Y65

Listings